Straumann Holding AG (OTCMKTS:SAUHY) Receives Average Recommendation of "Hold" from Analysts

Key Points

• Analysts give SAUHY an average recommendation of Hold from six brokerages—two sell, two hold, one buy and one strong buy—with Morgan Stanley and Citigroup recently reiterating underweight/sell views.
• Shares opened at $10.45, trading below both the 50‑day ($11.33) and 200‑day ($11.59) simple moving averages, and have a 1‑year range of $9.44 to $14.18.
• Straumann is a Swiss-based dental technology company that focuses on implant-supported restorations, biomaterials for bone and soft-tissue regeneration, prosthetic products, and digital dentistry solutions.

Straumann Holding AG (OTCMKTS:SAUHY - Get Free Report) has earned an average recommendation of "Hold" from the six brokerages that are presently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has given a strong buy rating to the company.

A number of analysts have issued reports on SAUHY shares. Morgan Stanley reissued an "underweight" rating on shares of Straumann in a research report on Monday, December 15th. Citigroup restated a "sell" rating on shares of Straumann in a research report on Wednesday, January 14th.

Straumann Price Performance

OTCMKTS:SAUHY opened at $10.45 on Tuesday. The business has a fifty day simple moving average of $11.33 and a two-hundred day simple moving average of $11.59. Straumann has a 1 year low of $9.44 and a 1 year high of $14.18.

Straumann Company Profile

Straumann OTCMKTS: SAUHY is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company's core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.